145 related articles for article (PubMed ID: 15480415)
1. Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion.
Neary CL; Nesterova M; Cho YS; Cheadle C; Becker KG; Cho-Chung YS
Oncogene; 2004 Nov; 23(54):8847-56. PubMed ID: 15480415
[TBL] [Abstract][Full Text] [Related]
2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
Nesterova MV; Cho-Chung YS
Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
[TBL] [Abstract][Full Text] [Related]
5. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
6. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
Neary CL; Cho-Chung YS
Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685
[TBL] [Abstract][Full Text] [Related]
7. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K
J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748
[TBL] [Abstract][Full Text] [Related]
8. Tumor reversion: protein kinase A isozyme switching.
Cho-Chung YS; Nesterova MV
Ann N Y Acad Sci; 2005 Nov; 1058():76-86. PubMed ID: 16394127
[TBL] [Abstract][Full Text] [Related]
9. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
10. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
Cvijic ME; Kita T; Shih W; DiPaola RS; Chin KV
Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081
[TBL] [Abstract][Full Text] [Related]
11. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A
Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656
[TBL] [Abstract][Full Text] [Related]
12. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
[TBL] [Abstract][Full Text] [Related]
14. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
Prinz A; Diskar M; Erlbruch A; Herberg FW
Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
[TBL] [Abstract][Full Text] [Related]
15. Differential localization of protein kinase A type II isozymes in the Golgi-centrosomal area.
Keryer G; Skålhegg BS; Landmark BF; Hansson V; Jahnsen T; Taskén K
Exp Cell Res; 1999 May; 249(1):131-46. PubMed ID: 10328961
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
[TBL] [Abstract][Full Text] [Related]
17. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.
Cho YS; Lee YN; Cho-Chung YS
Biochem Biophys Res Commun; 2000 Nov; 278(3):679-84. PubMed ID: 11095968
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
Vigil D; Blumenthal DK; Brown S; Taylor SS; Trewhella J
Biochemistry; 2004 May; 43(19):5629-36. PubMed ID: 15134437
[TBL] [Abstract][Full Text] [Related]
20. Conformational differences among solution structures of the type Ialpha, IIalpha and IIbeta protein kinase A regulatory subunit homodimers: role of the linker regions.
Vigil D; Blumenthal DK; Heller WT; Brown S; Canaves JM; Taylor SS; Trewhella J
J Mol Biol; 2004 Apr; 337(5):1183-94. PubMed ID: 15046986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]